authors
- F.J. Melgarosa Ramos
- A Mateu Puchades
- J Mataix Díaz
- L. Schneller-Pavelescu
- BELINCHON ROMERO, ISABEL
- S. Santos Alarcón
52-Week Mid-term Efficacy of Tildrakizumab in Moderate-to-severe Psoriasis: A Real-life Multicenter Experience
Academic Article
2024
- Overview
- Otro
- Ver todos